Your browser doesn't support javascript.
loading
Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients.
Einama, Takahiro; Yamagishi, Yoji; Takihata, Yasuhiro; Suzuki, Takafumi; Yamasaki, Tamio; Hirose, Yuichi; Kobayashi, Kazuki; Yonamine, Naoto; Fujinuma, Ibuki; Tsunenari, Takazumi; Koga, Makiko; Ishibashi, Yusuke; Nagata, Ken; Shiraishi, Takehiro; Nakazawa, Akiko; Iwasaki, Toshimitsu; Shinto, Eiji; Kato, Kimi; Sato, Kimiya; Ueno, Hideki; Kishi, Yoji; Tsuda, Hitoshi.
Affiliation
  • Einama T; Department of Surgery, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan. einama0722@ndmc.ac.jp.
  • Yamagishi Y; Department of Surgery, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan.
  • Takihata Y; Department of Surgery Basic Pathology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan.
  • Suzuki T; Department of Surgery, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan.
  • Yamasaki T; Department of Surgery, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan.
  • Hirose Y; Department of Surgery, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan.
  • Kobayashi K; Department of Surgery, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan.
  • Yonamine N; Department of Surgery, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan.
  • Fujinuma I; Department of Surgery, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan.
  • Tsunenari T; Department of Surgery, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan.
  • Koga M; Department of Surgery, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan.
  • Ishibashi Y; Department of Surgery, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan.
  • Nagata K; Department of Surgery, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan.
  • Shiraishi T; Department of Surgery, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan.
  • Nakazawa A; Department of Surgery, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan.
  • Iwasaki T; Department of Surgery, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan.
  • Shinto E; Department of Surgery, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan.
  • Kato K; Department of Surgery, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan.
  • Sato K; Department of Surgery Basic Pathology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan.
  • Ueno H; Department of Surgery Basic Pathology, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan.
  • Kishi Y; Department of Surgery, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan.
  • Tsuda H; Department of Surgery, National Defense Medical College, 3-2 Namiki, 359-8513, Tokorozawa, Saitama, Japan.
Biomark Res ; 9(1): 78, 2021 Oct 29.
Article in En | MEDLINE | ID: mdl-34715925

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Biomark Res Year: 2021 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Biomark Res Year: 2021 Document type: Article Affiliation country: Japan Country of publication: United kingdom